Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
Histate's biggest negative is that the machine costs 20k and sensitivity is appalling to ours in comparison. The biggest positives are the speed,that no chemicals /lengthy mixing is involved, recyclable cartridges will probably cost nothing , and they have already been through a UK approval which has taken 7 months - which is a head start.
Our machine I imagine would cost a few hundred pounds and have near 100% sensitivity and specificity and is simple to use by any numpty.
In short Histate is for airports, big stadium events, Schools.....Paraytec test is for everyone including laboratories, developing countries in which Histate will not be able to penetrate due cost of unit. In conclusion, We have more potential to scale .
"Binance BNB coin will be the new Ethereum....they are building an incredible ecosystem....think Amazon market place for crypto..."
Yah, every Crypto claims to be the next Bitcoin/ Ether store of value blah blah blah. BNB is using 20% of profits on burning their coins so is bound to be valuable but it doesn't support smart contracts. Having said that the BNB chain is built on the Cosmos SDK, so Cosmos might be the smarter bet.
Todays news probably benefits ETH and Coinbase's USDC more than anything else. Surprised ETH isn't up further tbh. There may not be an Ethereum killer.......Ethereum is the next Ethereum.
"UK stock market closed Easter." Correct but crypto is always trading 24-7. If you're worried about CGT there are plenty of ways around it.
Correct . Grayscale still hold bitcoin at the same levels they did last month. They have also massively diversified into other Crypto incl Stella, Mana, BAT. BAT is such genius btw, can see this being the website currency norm in decade. I can understand why did this because BAT and Livepeer will probably 100 bag in a couple of years yet btc will only 2-3-4 bag by then.
https://bitcointreasuries.org/
Grayscale will make MANA go 5 bag. They did it to Livepeer last week so watch out for MANA indeed.
Quite surprised at this tiny rise tbh. I suspect after June 21st when things are back to normal.... cannabis stocks will be booming.
Casper, you could of also bought BTC at £0.01 . Point is, always hold on to quality mate. Keep up the great work and spread the message further on the uber test we have here . We have bagged here and will continue to do so
Remember, Blue Days Matter
Yup, start topping up guys. Spread the word
No idea about Israeli tech. But it is clear this SPAC is aimed for the USA market. Today I expect us at 15p tbh.
Brh is brh ...in a class test of its own. Once us brh holders are done there we'd probably be pumping loose change into here to repay Trev . Credit due
Might as well put this up at 200p now. Easy money.
Any other blue day. Ok opening , would have preferred 125p.
Remember , BLUE DAYS MATTER
.....gold or silver. Unlike those commodities there is fixed limited supply of BTC. It is an asset class and continues to rise in value as demand increases against a dwindling supply. "
Fair enough, but like a lot of people , you also forgot to mention bitcoin is divisible by 100 million . Which is not a small amount.
Yup. Market cap Is too low at 5.5p / £3m.
I think of this exactly as AAA but for the cannabis sector. Heavy hitters on board . American link is obvious and it is clear we will be targeting the American market mainly.
I expect us to settled at £15m market cap. Very happy.
Yes very odd to see someone leave at this stage . Doesn't matter as long as TB is on board though
I see is opening strong at brh and closing huge tbh. FPP will also see me at multiple gains today. Just totally blessed.
https://www.linkedin.com/in/daniel-reshef-ab2020
Huge intent with heavy hitters now. Huge prospects. Shells like RDGC and a the others have nothing on this now.
£3m market cap. ROFL
Appointment of Director
Mon, 29th Mar 2021 07:00
RNS Number : 7338T
Fragrant Prosperity Holdings Ltd
29 March 2021
29 March 2021
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.
Fragrant Prosperity Holdings Limited
("FPP" or the "Company")
Appointment of Director
The Board of Directors of Fragrant Prosperity Holdings Limited, which is seeking an acquisition in several sectors but is currently focused on Cannabis Therapeutics, is pleased to announce the appointment of Dr. Daniel S. Reshef, MD, MPH, PhD to the Board of Directors as a non-executive director. This appointment will become effective as of March 31, 2021.
Dr. Daniel Reshef is a dual Israeli and USA Citizen, currently living in the USA, with strong ties to Israel, Israel medical research centres and a vast array of relationships in the global pharmaceutical sector.
Dr Reshef's extensive career with over twenty five years in drug development encompasses many facets of the Pharmaceutical sector, gained through senior management positions at leading companies such as Hoffman La Roche, Genentech, Bristol Myers Squibb, and in his current capacity as the Therapeutic Area Global Head for a major global Pharmaceutical Company. His scientific experience includes skills in regulatory, medical affairs, drug safety operations and clinical trials epidemiology with leadership experience in early drug development from phase 1 to phase IV, and in multiple therapeutic areas.
Dr. Reshef is a board-certified physician, graduate of the Hebrew University and Hadassah Medical School in Jerusalem, and has earned his MPH and PhD in Epidemiology from Johns Hopkins University.
Craig Marshak Chairman of Fragrant Prosperity commented: "I have personally known and worked with Dr. Daniel Reshef for well over 7 years, and have always been impressed with his world wide experience and skill set. I am delighted to welcome him to the Board and look forward to the additional expertise that he brings to the Company"
Current and previous Directorships within the last 5 years that Dr Reshef holds are set out below:
Current
Previous 5 years
ABTI - Alterola pharmaceuticals - Director
QEBR - Virtual Medical - Director, Vice Chair
Israel Venture Partners - Director
'In a new interview on Real Vision Finance, Brandt says Bitcoin could erupt nearly 260% from its current price of $56,000. According to the veteran analyst, the current logarithmic charts look like they did during the 2017 bull market just before Bitcoin’s big move upward.'
I'd expect $150k minimum this year. A severe crash will inevitably happen after though but this is all part of the halving cycle after effect every 4 years as we have statistically seen. 2022-2023 will inevitably be another rubbish couple of years, people will complain that is a Ponzi scheme, etc...scam, etc..etc... then the next halving in 2024 will see BTC at $500k+ Everything is already written already tbh.